GRI Bio, Inc. (GRI)
NASDAQ: GRI · IEX Real-Time Price · USD
1.670
-0.080 (-4.57%)
At close: Jul 19, 2024, 12:00 AM
1.620
-0.050 (-2.99%)
Pre-market: Jul 22, 2024, 9:07 AM EDT

GRI Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Market Capitalization
11441--
Market Cap Growth
-50.17%-66.18%-90.93%---
Enterprise Value
-3-1433-0-3
PE Ratio
0.01-0.10-1.15-4.38--
PB Ratio
0.364.83-2.277.00--
P/FCF Ratio
-0.27-0.14-3.40-4.90--
P/OCF Ratio
-0.27-0.14-3.41-4.90--
EV/Sales Ratio
-----0.48-
EV/EBITDA Ratio
0.130.05-1.70-3.610.011.07
EV/EBIT Ratio
0.130.05-1.70-3.580.011.07
EV/FCF Ratio
0.170.06-4.01-4.000.011.21
Debt / Equity Ratio
0.050.05-0.42--0.040.11
Debt / EBITDA Ratio
-0.010.00-0.26--0.01-0.10
Debt / FCF Ratio
-0.020.00-0.62--0.02-0.12
Quick Ratio
2.440.670.003.070.054.73
Current Ratio
2.641.090.163.330.304.85
Asset Turnover
00000.040
Interest Coverage
-12.96-5.26-3.93-580.44-140.82-16.58
Return on Equity (ROE)
-548.10%-795.50%-145.20%-102.20%-548.00%-205.80%
Return on Assets (ROA)
-290.50%-345.40%-64.70%-83.20%-184.40%-140.90%
Return on Capital (ROIC)
-416.75%-4171.06%236.43%-159.14%343.72%-88.75%
Earnings Yield
-1266.88%-1043.22%-87.06%-22.83%--
FCF Yield
-901.02%-720.02%-29.44%-20.40%--
Buyback Yield / Dilution
-2786.59%-257.81%-314.15%-45.12%-27.00%-121.47%
Total Shareholder Return
-2786.59%-257.81%-314.15%-45.12%-27.00%-121.47%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).